MedTrace Logo

Single Setting ERCP and Laparoscopic Cholecystectomy is a Safe Procedure in Patients With Cholecysto-Choledocholithiasis

NCT04213092 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2020-01-02

No results posted yet for this study

Summary

The ideal management of cholecysto-choledocholithiasis is an open cholecystectomy (OC) with the common bile duct (CBD) exploration worldwide. The single setting 2-stage approach- endoscopic retrograde cholangiopancreatography (ERCP), endoscopic sphincterotomy (EST), and CBD clearance followed by laparoscopic cholecystectomy (LC) offers an advantage, mainly by reducing the hospital stay, the cost, and the morbidity. Investigators did a prospective study in patients admitted for the management of the cholecysto-choledocholithiasis in the Department of Surgery at the Lumbini Medical College and Teaching Hospital from November 2012- October 2015. They underwent 2-stage ERCP+LC in a single setting and investigators compared them with 2-stage OC+CBD exploration in a single setting approach. The patients with the open procedure were the investigator's control groups. All the included cases in the study were elective.

Conditions

  • Choledocholithiasis With Cholecystitis With Obstruction
  • Choledocholithiasis With Acute and Chronic Cholecystitis
  • Cholelithiasis With Acute and Chronic Cholecystitis

Interventions

PROCEDURE

ERCP+LC

Patients in this group underwent a single setting ERCP and Laparoscopic cholecystectomy.

PROCEDURE

OC+CBD

Patients in this group underwent a single setting open cholecystectomy and open CBD exploration.

Sponsors & Collaborators

  • Lumbini Medical College

    lead OTHER

Principal Investigators

  • Chet R Pant, MD, MPH · Lumbini Medical College & Teaching Hospital Ltd, Kathmandu University

Eligibility

Min Age
13 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2015-10-31
Completion
2015-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04213092 on ClinicalTrials.gov